Research progress of behavioral variant frontotemporal dementia

<p><span style="font-size: 10px;">There is no epidemiological data of frontotemporal dementia (FTD) in China. The application of updated diagnostic criteria, publishing of frontotemporal lobar degeneration (FTLD) consensus in China, development of multimodal imaging and biom...

Full description

Bibliographic Details
Main Authors: Xiao-hua GU, Jun XU
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2015-07-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/1226
Description
Summary:<p><span style="font-size: 10px;">There is no epidemiological data of frontotemporal dementia (FTD) in China. The application of updated diagnostic criteria, publishing of frontotemporal lobar degeneration (FTLD) consensus in China, development of multimodal imaging and biomarkers promote the clinical understanding on behavioral variant frontotemporal dementia (bvFTD). There is still no drugs treating FTD approved by U.S. Food and Drug Administration (FDA). Multidisciplinary intervention may delay the progression of bvFTD.</span></p><p> </p><p><span style="font-size: 10px;"><strong>DOI: </strong>10.3969/j.issn.1672-6731.2015.07.006<br /></span></p>
ISSN:1672-6731